Download App

Log in to access Online Inquiry
Company Overview More
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O’Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O’Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
CEO: Ramani, Tushar M.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

CRH CRH PLC
40.380+0.710+1.79%
Post Mkt Price
40.38000.00%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30(FY)2020/12/31
Assets
Current assets
Cash, cash equivalents and short term investments
-25.1% 5.78B -- 5.78B -37.63% 6.29B 83.56% 7.72B
-Cash and cash equivalents
-25.1% 5.78B -- 5.78B -37.63% 6.29B 83.56% 7.72B
-Accounts receivable
12.67% 4.02B -- 4.57B 7.91% 5.31B 0.07% 3.57B
-Taxes receivable
16.67% 42M -- 42M 0% 29M 60.69% 36M
-Other receivables
-42.47% 298M -- -- -- -- -20.82% 518M
Inventory
15.85% 3.61B -- 3.61B 8.61% 3.19B 1.48% 3.12B
Prepaid assets
-- 251M -- -- -- -- -- --
Total current assets
-6.23% 14.04B -- 14.04B -17.48% 14.86B 29.93% 14.98B
Non current assets
Net PPE
0.96% 19.5B -- 19.5B 0.01% 19.1B -1.03% 19.32B
-Gross PPE
2.62% 33.75B -- -- -- -- 5.33% 32.88B
-Accumulated depreciation
-4.99% -14.24B -- -- -- -- -15.92% -13.57B
Goodwill and other intangible assets
5.07% 9.85B -- 9.85B 0.96% 9.47B -0.79% 9.37B
-Goodwill
4.64% 9.45B -- -- -- -- -0.38% 9.03B
-Other intangible assets
16.42% 397M -- -- -- -- -10.47% 341M
Financial assets
-47.28% 97M -- 97M -31.05% 131M 116.13% 184M
Defined pension benefit
-- 166M -- 166M -- -- -- --
Total non current assets
2.2% 30.63B -- 30.63B -0.43% 29.67B -0.99% 29.97B
Total assets
-0.61% 44.67B -- 44.67B -6.85% 44.53B 7.54% 44.94B
Liabilities
Current liabilities
Payables
32.41% 3.69B -- 6.24B 21.89% 6.88B -8.16% 2.79B
-accounts payable
26.02% 2.73B -- 5.69B 23.2% 6.2B -12.27% 2.16B
-Total tax payable
-11.15% 550M -- 550M 11.11% 680M 9.86% 619M
-Other payable
13633.33% 412M -- -- -- -- -10.73% 3M
Current provisions
-2.04% 479M -- 479M 12.53% 557M 9.41% 489M
Current debt and capital lease obligation
-45.52% 846M -- 846M -71.96% 452M 27.66% 1.55B
-Current debt
-56.32% 549M -- 549M -88.34% 155M 37.69% 1.26B
-Current capital lease obligation
0.34% 297M -- 297M 4.95% 297M -2.49% 296M
Other current liabilities
-2.94% 33M -- -- -- -- -32.55% 34M
Current liabilities
1.55% 7.58B -- 7.58B 1.85% 7.91B 4.45% 7.47B
Non current liabilities
Long term provisions
-1.68% 937M -- 937M 6.47% 921M 11.94% 953M
Long term debt and capital lease obligation
-8.01% 11.31B -- 11.31B -27.01% 12B 16.3% 12.3B
-Long term debt
-9.31% 9.94B -- 9.94B -29.45% 10.66B 19.31% 10.96B
-Long term capital lease obligation
2.61% 1.37B -- 1.37B 0.75% 1.34B -3.6% 1.34B
Derivative product liabilities
-- -- -- 0 -- -- -10.73% 1M
Other non current liabilities
-- 328M -- -- -- -- -- --
Total non current liabilities
-5.58% 16.18B -- 16.18B -21.62% 16.55B 13.7% 17.13B
Total liabilities
-3.42% 23.76B -- 23.76B -15.3% 24.46B 10.73% 24.6B
Shareholders'equity
Share capital
-7.19% 310M -- 310M -5.36% 318M 9.22% 334M
-common stock
-7.21% 309M -- 309M -5.37% 317M 9.29% 333M
-Preferred stock
0% 1M -- 1M 0% 1M -10.73% 1M
Retained earnings
70.95% 19.77B -- 19.77B 71.76% 19.08B 4.05% 11.57B
Paid-in capital
-- 0 -- 0 -- -- 2.37% 7.49B
Less: Treasury stock
-49.48% 195M -- 195M 3.15% 557M 6.03% 386M
Total stockholders'equity
2.94% 20.23B -- 20.23B 5.98% 19.38B 3.59% 19.66B
Noncontrolling interests
-1.59% 681M -- 681M 8.26% 695M 14.4% 692M
Total equity
2.78% 20.91B -- 20.91B 6.06% 20.07B 3.92% 20.35B
Currency Unit
USDUSDUSDUSD
Accounting Standards
NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%